Heron Therapeutics Inc (HRTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO, CA 92121

A P Pharma Inc. develops ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The company's main focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer.

Data based on most recent fiscal year report
Market Cap2.072 Billion Shares Outstanding90.05 Million Avg Volume1.339 Million
1-Yr BETA vs S&P TR1.092 Current Ratio4.86 Quick Ratio4.44
View SEC Filings from HRTX instead.

View recent insider trading info

Funds Holding HRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

24 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

24 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

  • Director
  • 10% Owner
7,910,575 2020-01-09 2

JOHNSON CRAIG A

  • Director
0 2020-01-09 1

DAVIS STEPHEN CEO

  • Officer
  • Director
0 2020-01-06 3

TANG KEVIN C

  • Director
  • 10% Owner
0 2019-12-20 2

ROSEN ROBERT

  • Director
0 2019-12-20 0

QUART BARRY D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-12-19 2

DRAZBA BRIAN G. CHIEF FINANCIAL OFFICER

  • Officer
37,500 2019-12-19 0

MANHARD KIMBERLY EXECUTIVE VP, DRUG DEVELOPMENT

  • Officer
  • Director
0 2019-12-19 3

POYHONEN JOHN EVP, CHIEF COMMERCIAL OFFICER

  • Officer
  • Director
0 2019-12-19 4

CHRISTIAN WAAGE

  • Director
0 2019-12-19 2

HOFFMAN ROBERT CFO & SVP, FINANCE

  • Officer
0 2019-12-19 1

ZERBE ROBERT L MD

0 2019-05-01 0

GODDARD PAUL

  • Director
No longer subject to file 2018-11-27 0

CLENDENINN NEIL JAMES

  • Director
0 2016-05-26 0

MARSHALL PAUL SVP, TECHNICAL OPERATIONS

  • Officer
2,200 2016-03-21 0

SPCH, LLC

MIDLER ANDREW R

  • EXITING 10% HOLDEREXITING 10% HOLDER
No longer subject to file 2014-12-31 0

SAVITR CAPITAL, LLC

  • EXITING 10% HOLDER
No longer subject to file 2014-12-31 0

GELDER MARK S. MD SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2014-12-12 0

TURNBULL GREG

  • Director
167,074 2014-02-27 0

WHELAN JOHN CFO

  • Officer
254,088 2013-07-18 0

ADAM MICHAEL A CHIEF OPERATING OFFICER

  • Officer
0 2013-02-08 0

SPCH, LLC

  • 10% Owner
0 2013-01-01 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
2,328,863 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
57,704 2012-03-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
232,011 2012-03-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
0 2012-01-27 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
450,461 2011-12-30 0

BARR JOHN VICE PRESIDENT OF R&D

  • Officer
0 2011-07-08 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
26,666,667 2011-07-01 0

ROSENBLATT TOBY

  • Director
210,234 2010-05-20 0

PRENTKI RONALD J PRESIDENT & CEO

  • Officer
  • Director
0 2010-02-17 0

TAYLOR ARTHUR T

  • Director
0 2008-06-18 0

RIEPENHAUSEN PETER

  • Director
71,900 2008-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JOHNSON CRAIG A - Director

2019-12-19 A 23,000 a 23,000 0.00 direct

DAVIS STEPHEN - Director

2019-12-19 A 15,500 a 15,500 0.00 direct

CHRISTIAN WAAGE - Director

2019-12-19 A 17,000 a 17,000 0.00 direct

POYHONEN JOHN - Director - Officer EVP, CHIEF COMMERCIAL OFFICER

2019-12-19 A 55,562 a 55,562 0.00 direct

MANHARD KIMBERLY - Director - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-12-19 A 120,000 a 120,000 0.00 direct

QUART BARRY D - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-19 A 325,000 a 325,000 0.00 direct

TANG KEVIN C - Director

2019-12-19 A 17,000 a 17,000 0.00 direct

HOFFMAN ROBERT - Officer CFO & SVP, FINANCE

2019-12-19 A 100,000 a 100,000 0.00 direct

MANHARD KIMBERLY - Director - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-11-29 M 24,000 $13.00 a 24,000 0.00 direct yes

MANHARD KIMBERLY - Director - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-11-29 M 24,000 d 58,416 0.00 direct yes

MANHARD KIMBERLY - Director - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-11-29 S 24,000 $26.00 d 0 0.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments